Emergence of Azole Resistance in Aspergillus
- PMID: 26398534
- DOI: 10.1055/s-0035-1562894
Emergence of Azole Resistance in Aspergillus
Abstract
Resistance to the azole antifungals itraconazole, voriconazole, and posaconazole in Aspergillus species is a growing concern. This is especially alarming for A. fumigatus, where acquired resistance has been documented in patients with invasive disease caused by this species that were exposed to these agents, as well as in azole-naive individuals. The primary mechanisms of resistance that have been described in clinical strains include different point mutations in the CYP51A gene, which encodes the enzyme responsible for converting lanosterol to ergosterol via demethylation. Some resistant isolates also contain a tandem repeat in the promoter region of this gene that causes increased expression. These mutations, including TR34/L98H and TR46/Y121F/T289A have also been found in the environment in several areas of the world and have been demonstrated to cause resistance to azole fungicides used in agriculture, thus raising the concern of environmental spread of resistance. Treatment options are limited in patients with infections caused by azole-resistant isolates and include amphotericin B formulations or combination therapy involving an echinocandin. However, there are few clinical data available to help guide therapy, and infections caused by resistant A. fumigatus isolates have been reported to have high mortality rates.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Similar articles
-
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.Future Microbiol. 2014;9(5):697-711. doi: 10.2217/fmb.14.27. Future Microbiol. 2014. PMID: 24957095 Review.
-
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525787 Free PMC article.
-
Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364. Epub 2014 Oct 9. J Antimicrob Chemother. 2015. PMID: 25301884
-
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012. Epub 2015 May 14. J Infect Chemother. 2015. PMID: 26048062
-
Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment?Med Mal Infect. 2020 Aug;50(5):389-395. doi: 10.1016/j.medmal.2019.07.014. Epub 2019 Aug 28. Med Mal Infect. 2020. PMID: 31472992 Review.
Cited by
-
New Insights into the Cyp51 Contribution to Azole Resistance in Aspergillus Section Nigri.Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00543-19. doi: 10.1128/AAC.00543-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31061160 Free PMC article.
-
Oral Lipid Nanocrystal Amphotericin B (MAT2203) for the Treatment of Invasive Fungal Infections.Open Forum Infect Dis. 2024 Jun 24;11(7):ofae346. doi: 10.1093/ofid/ofae346. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 38989533 Free PMC article.
-
Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results.Biomed Res Int. 2017;2017:9658018. doi: 10.1155/2017/9658018. Epub 2017 Apr 4. Biomed Res Int. 2017. PMID: 28473992 Free PMC article.
-
Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis.Pharmaceutics. 2019 Sep 3;11(9):456. doi: 10.3390/pharmaceutics11090456. Pharmaceutics. 2019. PMID: 31484389 Free PMC article.
-
APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01713-18. doi: 10.1128/AAC.01713-18. Print 2019 Feb. Antimicrob Agents Chemother. 2019. PMID: 30455236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical